<div class='specification'>
<p>Targeted Alpha Therapy (TAT) is a technique that involves using alpha-radiation to treat&nbsp;leukemia and other dispersed cancers.</p>
</div>

<div class='specification'>
<p>Yttrium-90 and lutetium-177 are used in radiotherapy.</p>
</div>

<div class='question' style='padding-left: 20px; padding-right: 20px;'>
<p>Explain why alpha-radiation is particularly suitable for this treatment.</p>
<div class='marks'>[2]</div>
<div class='question_part_label'>a.i.</div>
</div>
<div class='question' style='padding-left: 20px; padding-right: 20px;'>
<p>Outline how the alpha-radiation in TAT is directed to cancer cells.</p>
<div class='marks'>[1]</div>
<div class='question_part_label'>a.ii.</div>
</div>
<div class='question' style='padding-left: 20px; padding-right: 20px;'>
<p>Identify the type of radiation emitted by these two radioisotopes.</p>
<div class='marks'>[1]</div>
<div class='question_part_label'>b.i.</div>
</div>
<div class='question' style='padding-left: 20px; padding-right: 20px;'>
<p>State an equation for the one-step decay of yttrium-90.</p>
<div class='marks'>[1]</div>
<div class='question_part_label'>b.ii.</div>
</div>
<div class='question' style='padding-left: 20px; padding-right: 20px;'>
<p>The half-life of lutetium-177 is 6.75 days. Calculate the percentage remaining&nbsp;after 27 days.</p>
<div class='marks'>[1]</div>
<div class='question_part_label'>b.iii.</div>
</div>
